For the year ending 2025-12-31, RKDA has $6,546K in assets. $2,406K in debts. $259K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 259 | |||
| Short-term investments | 4,304 | |||
| Accounts receivable and other receivables, net of allowance for credit loss of 559 and 0 as of december 31, 2025 and 2024, respectively | 425 | |||
| Inventories | 1,212 | |||
| Note receivable - current, net of allowance for credit losses (note 8) | 0 | |||
| Prepaid expenses and other current assets | 156 | |||
| Current assets of discontinued operations - goodwheat | 0 | |||
| Total current assets | 6,356 | |||
| Property and equipment, gross | 1,907 | |||
| Less accumulated depreciation and amortization | 1,899 | |||
| Property and equipment, net | 8 | |||
| Right of use assets | 0 | |||
| Intangible assets, net | 39 | |||
| Note receivable - noncurrent, net of allowance for credit losses (note 8) | 0 | |||
| Other noncurrent assets | 143 | |||
| Total assets | 6,546 | |||
| Accounts payable and accrued expenses | 1,789 | |||
| Other current liabilities-Related Party | 0 | |||
| Operating lease liability - current | 0 | |||
| Other current liabilities-Nonrelated Party | 270 | |||
| Total current liabilities | 2,059 | |||
| Common stock warrant and option liabilities | 347 | |||
| Other noncurrent liabilities | 0 | |||
| Total liabilities | 2,406 | |||
| Common stock, 0.001 par value -150,000,000 shares authorized as of december 31, 2025 and december 31, 2024 1,373,120 and 1,364,940 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 65 | |||
| Additional paid-in capital | 285,292 | |||
| Accumulated deficit | -281,217 | |||
| Total stockholders' equity | 4,140 | |||
| Total liabilities and stockholders equity | 6,546 | |||
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)